URL: https://www.sciencedirect.com/science/article/abs/pii/S1871402118306684?via%3Dihub
Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publication Date: 03/2019
Summary: The significant results in both MetS biomarkers and the MoCA score suggest that a ketogenic diet may serve to rescue cognition in patients with mild AD. The results of this case study are particularly compelling for ApoE4 positive (ApoE4+) subjects as ketogenic protocols extend hope and promise for AD prevention.
Key Takeaways
ApoE4 is a genetic marker that is thought to increase one's risk for Alzheimer's disease. A ketogenic diet showed improvement in cognitive performance in ApoE4 positive patients with mild cognitive impairment.
Do You Have The ApoE4 Gene? Try Switching To a Ketogenic Diet For Alzheimer's Prevention